Imaging in Clinical Oncology, 1st Edition

  • Published By:
  • ISBN-10: 8847053854
  • ISBN-13: 9788847053854
  • DDC: 616.994075
  • Grade Level Range: College Freshman - College Senior
  • 609 Pages | eBook
  • Original Copyright 2014 | Published/Released May 2014
  • This publication's content originally published in print form: 2014

  • Price:  Sign in for price



This encompassing book is designed to contribute to a teamwork approach by promoting understanding between radiologists and clinical oncologists. All of the currently available imaging modalities of relevance in clinical oncology are covered, and the presentation of a broad spectrum of oncologic diseases (of most organ systems) on these modalities is discussed and illustrated. The role of multiparametric and multimodality imaging approaches providing both morphologic and functional information is considered in detail, and careful attention is paid to the latest developments in higher field (3T) MR imaging and advanced MR techniques such as diffusion-weighted imaging, diffusion tensor imaging, perfusion-weighted imaging and spectroscopy. The major challenge of incorporating progress in quantitative imaging technology into radiotherapy treatment planning, guidance, and monitoring is also addressed. This book will assist in refining the treatment approach in various oncologic diseases and organ systems based on specific imaging features. It will be of value to radiologists, oncologists, and other medical professionals involved in the diagnosis and treatment of oncology patients. ​

Table of Contents

Front Cover.
Half Title Page.
Title Page.
Copyright Page.
1: Introduction to Oncologic Imaging.
2: Molecular Imaging in Oncology: Hybrid Imaging and Personalized Therapy of Cancer.
3: Imaging Criteria for Tumor Treatment Response Evaluation.
4: Imaging in Radiation Therapy.
5: Interventional Radiology in Oncology.
6: Imaging Principles in Pediatric Oncology.
7: Bone and soft Tissue Tumors.
8: Introduction to Soft Tissue Sarcomas.
9: Introduction to Bone Sarcomas.
10: Introduction to Retroperitoneal Tumors.
11: Conventional Radiology of Bone and Soft Tissue Tumors.
12: US-CT-MRI Findings: Staging-Response-Restaging of Bone and Soft Tissue Tumors.
13: Positron Emission Tomography in Bone and Soft Tissue Tumors.
14: Clinical Implications of Soft Tissue Sarcomas.
15: Clinical Implications of Bone Sarcomas.
16: Clinical Implications of Retroperitoneal Sarcomas.
17: CNS Tumors.
18: Introduction to Brain Tumors.
19: Conventional Imaging in the Diagnosis of Brain Tumors.
20: Diagnostic Issues in Treating Brain Tumors.
21: Tumors of the Spinal Cord and Spinal Canal.
22: Advanced MRI Techniques in Brain Tumors.
23: PET/CT: Is There a Role?.
24: Clinical Implications of Brain Tumors.
25: Lung Cancer.
26: Lung Cancer.
27: Lung Cancer Screening in High-Risk Patients with Low-Dose Helical CT.
28: CT-MRI in Diagnosis and Staging in Lung Cancer.
29: PET-CT in Lung Cancer.
30: EBUS Staging and Lung Cancer.
31: Clinical Implications of Lung Cancer.
32: Head and Neck Cancer.
33: Introduction to Head and Neck Cancer.
34: US Findings in Head and Neck Cancer.
35: CT and MR Findings in Head and Neck Cancer.
36: PET-CT Findings in Head and Neck Cancer.
37: Clinical Implications of Head and Neck Cancer.
38: Lymphomas.
39: Introduction to Lymphomas.
40: Lymphomas: The Role of CT and MRI in Staging and Restaging.
41: Clinical Implications of the Role of 18FDG-PET/CT in Malignant Lymphomas.
42: Gynecologic Cancer.
43: Introduction to Gynecologic Cancer.
44: US Findings in Gynecologic Cancer.
45: CT-MR Findings in Cervical and Endometrial Cancer.
46: CT-MR Findings in Ovarian Cancer.
47: PET/CT with [18F]FDG in Cervical Cancer.
48: PET/CT with [18F]FDG in Ovarian Cancer.
49: PET/CT with [18F]FDG in Endometrial Cancer.
50: Clinical Implications of Gynecologic Cancer.
51: Breast Cancer.
52: Breast Cancer.
53: Mammographic Diagnosis of Breast Cancer.
54: US Findings in Breast Cancer.
55: MR Mammography.
56: Breast Cancer: PET/CT Imaging.
57: Clinical Implications of Breast Cancer.
58: Gastrointestinal Cancer.
59: Esophageal and Gastric Tumors Where the Clinician Requires Imaging.
60: Imaging Findings in Gastrointestinal Cancer: Esophagus, Stomach.
61: Clinical Implications.
62: Introduction to Liver Cancer.
63: Imaging Findings in Liver Malignancies.
64: Clinical Implications of Liver Malignancies.
65: Introduction to Pancreatic Cancer.
66: Imaging in Pancreatic Cancer.
67: Clinical Implications of Pancreatic Cancer.
68: Introduction to Peritoneal Cavity Carcinoma.
69: Imaging of Peritoneal Cavity Carcinoma.
70: Introduction to the Large Bowel.
71: CT and CT-Colonography.
72: MR Findings of Rectal Carcinoma.
73: PET-CT Staging of Rectal Carcinoma.
74: Clinical Implications of Large Bowel Carcinoma.
75: Neuroendocrine Tumors.
76: Introduction to Neuroendocrine Tumors.
77: Neuroendocrine Tumors.
78: Clinical Implications of Neuroendocrine Tumors.
79: Urogenital Cancer.
80: Introduction to Adrenal Cancer.
81: Ultrasound Findings in Adrenal Cancer.
82: CT and MRI Findings in Adrenal Cancer.
83: SPECT in Adrenal Glands.
84: PET/CT Findings in Adrenal Cancer.
85: Clinical Implications of Adrenal Cancer.
86: Introduction to Renal Cancer.
87: US Findings in Renal Cancer.
88: CT and MRI Findings in Renal Cancer.
89: PET/CT Findings in Renal Cancer.
90: Clinical Implications of Renal Cancer.
91: Introduction to Urothelial Cancer.
92: US Findings in Urothelial Cancer.
93: CT and MRI Findings in Urothelial Cancer.
94: Clinical Implications of Urothelial Cancer.
95: Introduction to Testicular Cancer.
96: US Findings in Testicular Cancer.
97: CT and MRI Findings in Testicular Cancer.
98: PET/CT Findings in Testicular Cancer.
99: Clinical Implications in Testicular Cancer.
100: Introduction to Prostate Cancer.
101: Endorectal Ultrasound and Prostate Cancer.
102: MRI in Prostate Cancer.
103: Nuclear Medicine Findings in Prostate Cancer.
104: Clinical Implications of Prostate Cancer.
105: Melanoma.
106: Introduction to Melanoma.
107: Imaging Findings in Melanoma.
108: Clinical Implications of Melanoma.